Pathstone Holdings
DNLI icon

Pathstone Holdings’s Denali Therapeutics DNLI Stock Holding History

Pathstone Holdings’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$630K Buy
45,040
+6,735
+18% +$94.2K ﹤0.01% 1608
2025
Q1 		$521K Buy
38,305
+17,081
+80% +$232K ﹤0.01% 1693
2024
Q4 		$433K Buy
+21,224
New +$433K ﹤0.01% 1790